Zobrazeno 1 - 10
of 12
pro vyhledávání: '"L. M. Hagerman"'
Autor:
A R, Imondi, P, Della Torre, G, Mazué, T M, Sullivan, T L, Robbins, L M, Hagerman, A, Podestà, G, Pinciroli
Publikováno v:
Cancer research. 56(18)
Dexrazoxane [(DZR), ADR 529, ICRF-187] ameliorates doxorubicin (DOX)-induced cardiotoxicity in animals, and is recommended as a cardioprotectant in patients receiving cumulative doses of DOX above 300 mg/m2. A DZR:DOX dose ratio of 10:1 is recommende
Autor:
D. L. Schneider, L. M. Hagerman
Publikováno v:
Experimental Biology and Medicine. 143:93-96
SummaryRats were fed diets containing medium-chain triglycerides or corn oil and graded levels of cholestyramine to determine if fatty acid competition influences resin bile salt binding ability. When low levels of the resin were fed, MCT promoted a
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 242(1)
The plasma and urinary concentrations of unchanged 14C-sulpiride were measured in the dog following i.v. and oral administration. Bioavailability of the oral hydrochloride solution was 85% and that of the free base suspension was 75%. Sulpiride equil
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 232(1)
The metabolism of 14C-carbonyl-sulpiride (form A) and of 14C-3, 4 pyrrolidine-sulpiride (form B) was studied in the rhesus monkey and man. In the monkey, the metabolites in both the urine and the bile were the same with form A and form B: 60-80% sulp
Publikováno v:
Polymeric Materials in Medication ISBN: 9781489922472
The maleic anhydride: divinyl ether (MVE-2) used in this study is a water soluble anionic polymer with a mean molecular weight of 11, 000. The demonstration in laboratory animals of immunologic and antitumor properties by this polymer has led to its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f16bee312327adc62d3f3a1bac1679b8
https://doi.org/10.1007/978-1-4899-2245-8_12
https://doi.org/10.1007/978-1-4899-2245-8_12
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 247(2)
The in vitro dissolution rates from four tablet formulations and one capsule formulation were measured in simulated gastric and simulated intestinal fluids. The dissolution t50% in simulated gastric fluid ranged from 1.5 min to 30 min and in simulate
Autor:
E. Baraona, R. Pirola, C. S. Lieber, J. W. Barnhart, J. D. Johnson, D. J. Rytter, R. B. Failey, R. Beckmann, G. Hillmann, F. Lagler, W. Linlz, W. Vollenberg, Donald Berkowitz, Arthur Bernstein, Franklin Simon, William Warner, A. Bizzi, A. M. Codegoni, A. Medea, S. Garattini, S. Bjorkerud, G. Bondjers, J. Boberg, L. A. Carlson, U. Freyschuss, B. Lassers, M. Wahlqvist, A. G. Olsson, S. Froberg, L. Oro, S. Rossner, G. Walldius, R. W. Butcher, Virgilio Bosch, Halina C. Mendez, German Camejo, H. B. Brewer, R. Shulman, P. Herbert, R. Ronan, K. Wehrly, D. Brunner, S. Altman, K. Loebl, M. Burstein, H. R. Scholnick, H. Richard Casdorph, Robert Ausman, Thomas H. Schmitz, M. N. Cayen, D. Dvornik, W. E. Connor, A. Wartman, D. Wittiak, G. Crepaldi, D. Fedele, R. Fellin, G. Bagnariol, G. Briani, Colin Dalton, Herbert Sheppard, J. L. de Gennes, G. Turpin, J. Truffert, Mary E. Dempsey, Mary C. Ritter, Donald T. Witiak, H. Ditschuneit, H. H. Ditschuneit, H. U. Klor, D. Rakow, P. Schwandt, P. Dorigo, G. Fassina, Gregory S. Duboff, Charles H. Eades, E. Schwartz, D. Abrutyn, K. David, G. Edwards, Margaret R. Hawkins, C. D. Eskelson, L. A. Meeks, R. G. Lamb, L. L. Adams, H. J. Fallon, Elaine B. Feldman, Charles Y. Cheng, Dolores H. Henderson, H. Frost, P. Heimstadt, Arlene S. Garfinkel, Michael C. Schotz, E. Stewart, V. V. Glaviano, T. N. Masters, Charles J. Glueck, Martin Gold, Henry Altschuler, A. Woldow, Y. Goto, Y. Nakamura, E. Asano, H. Nakamura, H. Greten, H. Wengeler, D. Seidel, H. Wieland, F. A. Gries, H. D. Miss, H. Canzler, T. Koschinsky, K. H. Vogelberg, K. Jahnke, Kare Gundersen, F. P. Kupiecki, Georges Hartmann, P. Hill, J. F. Douglas, A. N. Howard, D. E. Hyams, S. K. Hsia, James E. Fulton, Karl Huth, Arnold Kaplan, Masao Kariya, Takashi Kariya, Thomas R. Blohm, J. Martin Grisar, Roger A. Parker, Jeanne R. Martin, S. L. Katyal, J. Saha, J. J. Kabara, A. N. Klimov, O. K. Dokusova, L. A. Petrova, E. D. Poliakova, T. A. Klimova, B. J. Kudchodkar, L. Horlick, H. S. Sodhi, D. J. Nazir, Peter T. Kuo, H. Lengsfeld, H. Gallo-Torres, V. V. Lyachovich, I. B. Tsyrlcv, V. M. Mishin, O. A. Gromova, Hans J. Meyer, M. A. Mishkel, L. M. Morrison, O. A. Schjeide, G. S. Bajwa, B. H. Ershoff, C. D. Moutafis, N. B. Myant, David T. Nash, D. M. Ottenstein, W. R. Supina, D. A. Bartley, Nicholas Pelick, William R. Owen, E. Panak, J. Daver, M. Podesta, E. Edmond, J. Papenberg, G. Schlierf, H. Peeters, V. Blaton, B. Declercq, D. Vandamme, Joseph N. Pereira, Gerald A. Mears, Gerald F. Holland, A. A. Polachek, H. M. Katz, M. Littman, N. S. Radin, R. C. Arora, A. Lazzarini Robertson, R. Sanwald, H. Wagener, Terence J. Scallen, H. B. Skrdlant, M. V. Srikantaiah, Robert Scheig, Guenter Schlierf, Eckehard Dorow, D. L. Schneider, L. M. Hagerman, P. Segal, P. S. Roheim, H. A. Eder, David J. Shapiro, Victor W. Rodwell, Charles M. Siegfried, William H. Elliott, M. C. Stone, T. B. S. Dick, M. T. Ravi Subbiah, Bruce A. Kottke, William J. Martin, Kay Tanaka, Kurt J. Isselbacher, G. R. Thompson, J. D. Cameron, T. J. Peters, C. N. C. Drey, K. Toki, H. Nakatani, E. G. Tombropoulos, A. S. Truswell, G. Watermeyer, J. I. Mann, M. Vavrecka, Joseph F. Weiss, Joseph Ransohoff, Herbert J. Kayden, A. Weizel, Lawrence W. White, J. P. D. Wilson, D. J. Galton, Akira Yamamoto, Susumu Adachi, Katsunori Ishikawa, Teruo Kitani, Terushi Nasu, Yoshitake Shinji, Ko-Ichi Seki, Mitsuo Nishikawa, Nepomuk Zollner, Gunther Wolfram
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781468475494
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9314dd22fbbd922da876e2fee24b652
https://doi.org/10.1007/978-1-4684-7547-0_24
https://doi.org/10.1007/978-1-4684-7547-0_24
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 143(1)
SummaryWhen cholestyramine was incubated with pure bile salts in isotonic saline, it preferentially bound taurine-conjugated bile salts and dihydroxy bile salts as compared with the respective glycine conjugates and trihydroxy bile salts. Addition of
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 139(1)
SummaryCholestyramine (50-75 μ in diameter) was incubated with graded levels of taurocholate, glycocholate, taurodeoxycholate, or glycodeoxycholate in 0.3 M phosphate buffer. The resin showed a preference for taurine conjugates over glycine conjugat
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 139(1)
SummaryIn the absence of cholestyramine both glycine- and taurine-conjugated bile salts were rapidly absorbed from the rat ileum. Equilibration of bile salts with the resin prior to ileal instillation retarded, but did not completely interrupt, bile